NantHealth, Inc.: Nasdaq/NYSE listing notice — NantHealth to be delisted from Nasdaq on May 24, 2023; plans OTCQB listing

NantHealth, Inc.

Withdrew hearing request; Nasdaq will suspend trading May 24 due to failure to meet $15M public float requirement.
Company applied for OTCQB Venture Market quotation; expects continued reporting company status.
Shares may temporarily trade on OTC Pink until OTCQB transfer finalized.
Previously disclosed non-compliance on May 2, 2023; compliance period ended May 1.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

NantHealth, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(C)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: market value
Rules: 5450(b)(2)(C)

Exact text from the filing

May 22, 2023, the Company received notice from Nasdaq that its shares will be suspended at the open of business on May 24, 2023. Nasdaq is expected to file a Form 25 Notification of Delisting with the Securities Exchange Commission when all internal procedural periods have run. The Company expects and plans for its shares of common stock to be quoted by the OTC Markets Group, Inc. (“OTC”) upon being delisted from Nasdaq and has submitted an application to have its securities traded on the OTCQB Venture Market (“OTCQB”) of OTC. While the Company intends to have its common stock quoted on the OT

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001566469-23-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.